Isolation and expression of an altered mouse dihydrofolate reductase cDNA.

PubWeight™: 5.46‹?› | Rank: Top 1%

🔗 View Article (PMC 393852)

Published in Proc Natl Acad Sci U S A on May 01, 1983

Authors

C C Simonsen, A D Levinson

Articles citing this

(truncated to the top 100)

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A (1993) 9.17

Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol Cell Biol (1985) 7.49

Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J (1987) 7.32

Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci U S A (1990) 6.66

Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol (1991) 6.19

Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci U S A (1988) 5.92

Comparison of intron-dependent and intron-independent gene expression. Mol Cell Biol (1988) 4.75

Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci U S A (1990) 3.98

Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A (1986) 3.68

The herpes simplex virus 1 RNA binding protein US11 is a virion component and associates with ribosomal 60S subunits. J Virol (1992) 2.88

The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J Virol (1991) 2.81

A generic intron increases gene expression in transgenic mice. Mol Cell Biol (1991) 2.75

Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol (1988) 2.70

Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo. Proc Natl Acad Sci U S A (1986) 2.69

Tunicamycin treatment of CHO cells abrogates multiple blocks to retrovirus infection, one of which is due to a secreted inhibitor. J Virol (1992) 2.45

A human cell factor is essential for HIV-1 Rev action. EMBO J (1990) 2.43

Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J Virol (1996) 2.36

Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus. Nucleic Acids Res (1991) 2.29

Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J Virol (1986) 2.24

Glycoprotein D of herpes simplex virus encodes a domain which precludes penetration of cells expressing the glycoprotein by superinfecting herpes simplex virus. J Virol (1990) 2.17

Identification of the type I trimethoprim-resistant dihydrofolate reductase specified by the Escherichia coli R-plasmid R483: comparison with procaryotic and eucaryotic dihydrofolate reductases. J Bacteriol (1983) 2.15

Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J Virol (1992) 2.15

Retroviral transfer of genes into canine hemopoietic progenitor cells in culture: a model for human gene therapy. Proc Natl Acad Sci U S A (1986) 2.14

Endocytosis of glycophospholipid-anchored and transmembrane forms of CD4 by different endocytic pathways. EMBO J (1992) 2.09

Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol Cell Biol (1988) 2.08

Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. Proc Natl Acad Sci U S A (1988) 2.06

Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest (1990) 2.02

The rubella virus E1 glycoprotein is arrested in a novel post-ER, pre-Golgi compartment. J Cell Biol (1992) 2.00

Intracellular transport and secretion of hepatitis B surface antigen in mammalian cells. J Virol (1984) 1.95

CG dinucleotide clusters in MHC genes and in 5' demethylated genes. Nucleic Acids Res (1984) 1.90

Construction and properties of a cell line constitutively expressing the herpes simplex virus glycoprotein B dependent on functional alpha 4 protein synthesis. J Virol (1986) 1.89

Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci U S A (1993) 1.85

Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference. J Virol (1989) 1.83

c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells. Mol Cell Biol (1988) 1.76

Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency. J Virol (1992) 1.74

Human purine nucleoside phosphorylase and adenosine deaminase: gene transfer into cultured cells and murine hematopoietic stem cells by using recombinant amphotropic retroviruses. Mol Cell Biol (1987) 1.73

Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles. Proc Natl Acad Sci U S A (1986) 1.69

Regulated degradation of ornithine decarboxylase requires interaction with the polyamine-inducible protein antizyme. Mol Cell Biol (1992) 1.57

Molecular mechanisms of drug resistance. Biochem J (1990) 1.56

Transformation of cultured Drosophila melanogaster cells with a dominant selectable marker. Mol Cell Biol (1985) 1.53

Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity. J Virol (1988) 1.51

Conservation of promoter sequence but not complex intron splicing pattern in human and hamster genes for 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mol Cell Biol (1987) 1.45

Selection and amplification of heterologous genes encoding adenosine deaminase in mammalian cells. Proc Natl Acad Sci U S A (1986) 1.43

Efficient insertion of genes into the mouse germ line via retroviral vectors. Proc Natl Acad Sci U S A (1985) 1.42

Intron requirement for expression of the human purine nucleoside phosphorylase gene. Nucleic Acids Res (1992) 1.42

Complete nucleotide and deduced amino acid sequence of bovine phenylethanolamine N-methyltransferase: partial amino acid homology with rat tyrosine hydroxylase. Proc Natl Acad Sci U S A (1986) 1.34

Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance. Mol Cell Biol (1989) 1.33

Evaluation of selectable markers for rice transformation. Plant Physiol (1989) 1.32

Sequence structures of a mouse major urinary protein gene and pseudogene compared. EMBO J (1985) 1.31

Polyamine-mediated regulation of mouse ornithine decarboxylase is posttranslational. Mol Cell Biol (1989) 1.30

Heterologous expression and characterization of the human R-ras gene product. Mol Cell Biol (1987) 1.27

Regulation of glycoprotein D synthesis: does alpha 4, the major regulatory protein of herpes simplex virus 1, regulate late genes both positively and negatively? J Virol (1988) 1.26

Circular DNA of 3T6R50 double minute chromosomes. Nucleic Acids Res (1988) 1.24

Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow. J Exp Med (1987) 1.24

High-frequency germinal transposition of DsALS in Arabidopsis. Proc Natl Acad Sci U S A (1993) 1.24

Insertional mutation in a transgenic mouse allelic with Purkinje cell degeneration. Proc Natl Acad Sci U S A (1989) 1.20

Development of a plant transformation selection system based on expression of genes encoding gentamicin acetyltransferases. Plant Physiol (1988) 1.20

Differential amplification and disproportionate expression of five genes in three multidrug-resistant Chinese hamster lung cell lines. Mol Cell Biol (1986) 1.20

Phosphorylation of protein kinase C sites in NBD1 and the R domain control CFTR channel activation by PKA. J Physiol (2003) 1.19

Expression and regulation of glycoprotein C gene of herpes simplex virus 1 resident in a clonal L-cell line. J Virol (1986) 1.18

Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors. EMBO J (1989) 1.17

High rate of mismatch extension during reverse transcription in a single round of retrovirus replication. Proc Natl Acad Sci U S A (1994) 1.16

Expression of amplified DNA sequences for ornithine transcarbamylase in HeLa cells: arginine residues may be required for mitochondrial import of enzyme precursor. J Cell Biol (1985) 1.14

The former annotated human pseudogene dihydrofolate reductase-like 1 (DHFRL1) is expressed and functional. Proc Natl Acad Sci U S A (2011) 1.12

Transfer of genes into hematopoietic cells using recombinant DNA viruses. Proc Natl Acad Sci U S A (1985) 1.12

Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol (1994) 1.10

High-level production of recombinant proteins in CHO cells using a dicistronic DHFR intron expression vector. Nucleic Acids Res (1996) 1.04

Electric field-mediated gene transfer: characterization of DNA transfer and patterns of integration in lymphoid cells. Nucleic Acids Res (1988) 1.04

High-level expression of c-H-ras1 fails to fully transform rat-1 cells. Mol Cell Biol (1988) 1.03

Analysis of transport and targeting of syndecan-1: effect of cytoplasmic tail deletions. Mol Biol Cell (1994) 1.01

Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector. J Virol (1990) 1.01

Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells. Mol Cell Biol (1991) 1.01

3T3 fibroblasts transfected with a cDNA for mitochondrial aspartate aminotransferase express plasma membrane fatty acid-binding protein and saturable fatty acid uptake. Proc Natl Acad Sci U S A (1995) 1.00

Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc Natl Acad Sci U S A (1994) 0.96

Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation. Mol Cell Biol (1990) 0.96

Molecular cloning of the cDNA for a mutant mouse ribonucleotide reductase M1 that produces a dominant mutator phenotype in mammalian cells. Mol Cell Biol (1988) 0.95

MDM2 regulates dihydrofolate reductase activity through monoubiquitination. Cancer Res (2008) 0.95

Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation. Proc Natl Acad Sci U S A (1993) 0.94

Expression of a cDNA sequence encoding human purine nucleoside phosphorylase in rodent and human cells. Mol Cell Biol (1985) 0.90

A foreign dihydrofolate reductase gene in transgenic mice acts as a dominant mutation. Mol Cell Biol (1986) 0.90

Expression of the plasmid-encoded type I dihydrofolate reductase gene in cultured mammalian cells: a novel selectable marker. Nucleic Acids Res (1988) 0.90

Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization. Proc Natl Acad Sci U S A (1986) 0.90

Adenovirus type 12-induced fragility of the human RNU2 locus requires U2 small nuclear RNA transcriptional regulatory elements. Mol Cell Biol (1995) 0.88

Recombinant human sulphamidase: expression, amplification, purification and characterization. Biochem J (1998) 0.88

Transfer of a mutant dihydrofolate reductase gene into pre- and postimplantation mouse embryos by a replication-competent retrovirus vector. J Virol (1989) 0.84

Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells. Nucleic Acids Res (1990) 0.83

Presence and transcription of intracisternal A-particle-related sequences in CHO cells. J Virol (1990) 0.83

Membrane-anchored form of v-sis/PDGF-B induces mitogenesis without detectable PDGF receptor autophosphorylation. J Cell Biol (1991) 0.83

Ability of methotrexate to inhibit translocation to the cytosol of dihydrofolate reductase fused to diphtheria toxin. Biochem J (1996) 0.82

Isolation of recessive (mediator-) revertants from NIH 3T3 cells transformed with a c-H-ras oncogene. Mol Cell Biol (1990) 0.82

Evaluating the bottlenecks of recombinant IgM production in mammalian cells. Cytotechnology (2014) 0.81

Expression of the mouse dihydrofolate reductase cDNA in B. subtilis: a system to select mutant cDNAs coding for methotrexate resistant enzymes. Nucleic Acids Res (1984) 0.79

Expression of the mouse serum albumin gene introduced into differentiated and dedifferentiated rat hepatoma cells. Proc Natl Acad Sci U S A (1985) 0.78

Amplification and expression of heterologous ornithine decarboxylase in Chinese hamster cells. Mol Cell Biol (1988) 0.77

A role for Drosophila in understanding drug-induced cytotoxicity and teratogenesis. Cytotechnology (2008) 0.77

Systemic resistance to methotrexate in transgenic mice carrying a mutant dihydrofolate reductase gene. Proc Natl Acad Sci U S A (1986) 0.77

High-throughput sample preparation for protein or peptide structural characterization. J Biomol Tech (1999) 0.75

Rapid in vitro derivation of endothelium directly from human cancer cells. PLoS One (2013) 0.75

Epidermal growth factor (EGF) modulation of feline sarcoma virus fms tyrosine kinase activity, internalization, degradation, and transforming potential in an EGF receptor/v-fms chimera. J Virol (1994) 0.75

Evidence for Retromutagenesis as a Mechanism for Adaptive Mutation in Escherichia coli. PLoS Genet (2015) 0.75

Articles cited by this

Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68

A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res (1979) 214.95

A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36

Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc Natl Acad Sci U S A (1975) 77.46

Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79

A system for shotgun DNA sequencing. Nucleic Acids Res (1981) 52.99

Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc Natl Acad Sci U S A (1981) 22.21

DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci U S A (1979) 21.22

Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell (1979) 21.15

Construction of plasmids carrying the cI gene of bacteriophage lambda. Proc Natl Acad Sci U S A (1976) 13.10

A new dominant hybrid selective marker for higher eukaryotic cells. J Mol Biol (1981) 9.51

Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. J Biol Chem (1978) 9.13

Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids. Nature (1981) 8.66

Mapping temperature-sensitive and host-range mutations of adenovirus type 5 by marker rescue. Virology (1978) 8.28

Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc Natl Acad Sci U S A (1980) 7.84

Expression of human immune interferon cDNA in E. coli and monkey cells. Nature (1982) 6.55

Isolation and partial characterization of three methotrexate-resistant phenotypes from Chinese hamster ovary cells. Somatic Cell Genet (1976) 4.55

Structure and genomic organization of the mouse dihydrofolate reductase gene. Cell (1980) 4.25

Gene amplification and drug resistance in cultured murine cells. Science (1978) 4.25

Rabbit beta-globin mRNA production in mouse L cells transformed with cloned rabbit beta-globin chromosomal DNA. Nature (1979) 3.88

Transformation of mammalian cells with an amplifiable dominant-acting gene. Proc Natl Acad Sci U S A (1980) 3.39

Structure of amplified normal and variant dihydrofolate reductase genes in mouse sarcoma S180 cells. J Biol Chem (1982) 3.25

Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary dna gene. J Mol Biol (1982) 3.17

Nucleotide sequence surrounding multiple polyadenylation sites in the mouse dihydrofolate reductase gene. J Biol Chem (1982) 2.59

Crystal structure of avian dihydrofolate reductase containing phenyltriazine and NADPH. J Biol Chem (1982) 2.45

Expression of abbreviated mouse dihydrofolate reductase genes in cultured hamster cells. Proc Natl Acad Sci U S A (1982) 2.45

Transformation of the gene for hypoxanthine phosphoribosyltransferase. Somatic Cell Genet (1979) 2.42

Construction of a modular dihydrofolate reductase cDNA gene: analysis of signals utilized for efficient expression. Mol Cell Biol (1982) 2.33

Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA. Proc Natl Acad Sci U S A (1982) 2.20

Plasmid-directed synthesis of hepatitis B surface antigen in monkey cells. Mol Cell Biol (1983) 1.85

Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts. J Biol Chem (1981) 1.71

Unstable amplification of an altered dihydrofolate reductase gene associated with double-minute chromosomes. Cell (1981) 1.59

Two different species of dihydrofolate reductase in mammalian cells differentially resistant to amethopterin and methasquin. Cancer Res (1972) 1.46

Effect of a single amino acid substitution on Escherichia coli dihydrofolate reductase catalysis and ligand binding. J Biol Chem (1981) 1.39

On the nature of a transport alteration determining resistance to amethopterin in the L1210 leukemia. Cancer Res (1968) 1.06

Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofoltate reductase. Eur J Cancer (1977) 1.02

The amino acid sequence of dihydrofolate reductase from the mouse lymphoma L1210. J Biol Chem (1979) 0.99

A methotrexate insensitive variant of folate reductase present in two lines of methotrexate-resistant L5178Y cells. Eur J Cancer (1980) 0.92

Chromosome-mediated transfer and amplification of an altered mouse dihydrofolate reductase gene. Somatic Cell Genet (1982) 0.90

Articles by these authors

Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein. Cell (1978) 11.17

Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature (1983) 10.64

Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (src). Proc Natl Acad Sci U S A (1979) 7.55

The primary structure and genetic organization of the bovine papillomavirus type 1 genome. Nature (1982) 7.24

Expression of human immune interferon cDNA in E. coli and monkey cells. Nature (1982) 6.55

Comparative biochemical properties of normal and activated human ras p21 protein. Nature (1984) 6.50

Biological properties of human c-Ha-ras1 genes mutated at codon 12. Nature (1984) 6.21

Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature (1983) 5.90

Initiation of translation at internal AUG codons in mammalian cells. Nature (1984) 5.34

Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed amino acid sequence for gene product. Nature (1980) 5.22

The protein encoded by the transforming gene of avian sarcoma virus (pp60src) and a homologous protein in normal cells (pp60proto-src) are associated with the plasma membrane. Proc Natl Acad Sci U S A (1980) 4.99

Expression of active human factor VIII from recombinant DNA clones. Nature (1984) 4.36

Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations. Nature (1983) 4.15

Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29. Nature (1983) 4.06

Structural and functional domains of the Rous sarcoma virus transforming protein (pp60src). Proc Natl Acad Sci U S A (1981) 4.04

The purified product of the transforming gene of avian sarcoma virus phosphorylates tyrosine. J Biol Chem (1980) 3.95

Identification of nuclear proteins encoded by viral and cellular myc oncogenes. Nature (1984) 3.86

Analysis of processing and polyadenylation signals of the hepatitis B virus surface antigen gene by using simian virus 40-hepatitis B virus chimeric plasmids. Mol Cell Biol (1983) 3.63

Corrections to the nucleotide sequence of the src gene of Rous sarcoma virus. Nature (1983) 3.42

Structure of amplified normal and variant dihydrofolate reductase genes in mouse sarcoma S180 cells. J Biol Chem (1982) 3.25

The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb. Cell (1983) 3.21

Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell (1994) 2.88

Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29. Proc Natl Acad Sci U S A (1983) 2.66

Expression of abbreviated mouse dihydrofolate reductase genes in cultured hamster cells. Proc Natl Acad Sci U S A (1982) 2.45

Heterogeneity at the 5' termini of mouse dihydrofolate reductase mRNAs. Evidence for multiple promoter regions. J Biol Chem (1985) 2.29

Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J Virol (1986) 2.24

Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. Science (1993) 2.17

Two cellular proteins that immunoprecipitate with the transforming protein of Rous sarcoma virus. Virology (1981) 2.16

Identification of the type I trimethoprim-resistant dihydrofolate reductase specified by the Escherichia coli R-plasmid R483: comparison with procaryotic and eucaryotic dihydrofolate reductases. J Bacteriol (1983) 2.15

A mutation at the ATP-binding site of pp60v-src abolishes kinase activity, transformation, and tumorigenicity. Mol Cell Biol (1985) 2.12

The structure and protein kinase activity of proteins encoded by nonconditional mutants and back mutants in the sec gene of avian sarcoma virus. Virology (1981) 2.06

Inhibitory and stimulatory G proteins of adenylate cyclase: cDNA and amino acid sequences of the alpha chains. Proc Natl Acad Sci U S A (1986) 2.03

Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest (1990) 2.02

Phosphorylation of tyrosine-416 is not required for the transforming properties and kinase activity of pp60v-src. Cell (1983) 1.98

The oncogenic activation of human p21ras by a novel mechanism. Science (1986) 1.89

Origin and function of avian retrovirus transforming genes. Cold Spring Harb Symp Quant Biol (1980) 1.89

Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins. J Neurosci (1995) 1.85

Plasmid-directed synthesis of hepatitis B surface antigen in monkey cells. Mol Cell Biol (1983) 1.85

Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci U S A (1993) 1.82

Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors (1990) 1.72

The group C adenovirus tumor antigens: identification in infected and transformed cells and a peptide map analysis. Cell (1977) 1.65

The product of the avian erythroblastosis virus erbB locus is a glycoprotein. Cell (1983) 1.62

Direct expression of hepatitis B surface antigen in monkey cells from an SV40 vector. DNA (1982) 1.62

Recombinant TGF-beta 1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-beta 1 complex. Growth Factors (1989) 1.51

Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity. J Virol (1988) 1.51

Detection of antibodies to herpes simplex virus with a continuous cell line expressing cloned glycoprotein D. Science (1983) 1.49

Signal transduction by the platelet integrin alpha IIb beta 3: induction of calcium oscillations required for protein-tyrosine phosphorylation and ligand-induced spreading of stably transfected cells. Mol Biol Cell (1992) 1.47

Bacterial expression of an enzymatically active protein encoded by RSV src gene. Nature (1982) 1.44

Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest (1993) 1.42

Expression of hepatitis B virus surface antigen in yeast. Nucleic Acids Res (1983) 1.39

The transforming growth factor-betas. A new family of immunoregulatory molecules. Ann N Y Acad Sci (1990) 1.36

A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene. Nature (1988) 1.32

RNA synthesis of vesicular stomatitis virus-infected cells: in vivo regulation of replication. J Virol (1979) 1.29

Expression of the H-ras proto-oncogene is controlled by alternative splicing. Cell (1989) 1.29

Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1. J Exp Med (1990) 1.28

Suppression of mammalian 5' splice-site defects by U1 small nuclear RNAs from a distance. Proc Natl Acad Sci U S A (1994) 1.23

In vivo and in vitro phosphorylation of the adenovirus type 5 single strand-specific DNA-binding protein. Virology (1977) 1.20

Expression of normal and activated human Ha-ras cDNAs in Saccharomyces cerevisiae. Mol Cell Biol (1985) 1.19

Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells. Blood (1991) 1.17

The human transforming growth factor alpha promoter directs transcription initiation from a single site in the absence of a TATA sequence. Mol Cell Biol (1988) 1.16

Adenovirus VAI-RNA regulates gene expression by controlling stability of ribosome-bound RNAs. EMBO J (1989) 1.14

Characterization of vesicular stomatitis virus replicating complexes isolated in renografin gradients. Virology (1979) 1.10

Biochemical characterization of polypeptides encoded by mutated human Ha-ras1 genes. Mol Cell Biol (1986) 1.09

High-level expression of c-H-ras1 fails to fully transform rat-1 cells. Mol Cell Biol (1988) 1.03

U1 small nuclear RNAs with altered specificity can be stably expressed in mammalian cells and promote permanent changes in pre-mRNA splicing. Mol Cell Biol (1993) 0.98

Further characterization of the replicative complex of vesicular stomatitis virus. J Virol (1979) 0.98

Chimeric proteins define variable and essential regions of Ha-ras-encoded protein. Proc Natl Acad Sci U S A (1988) 0.98

Activation of c-Jun transcription factor by substitution of a charged residue in its N-terminal domain. Nucleic Acids Res (1994) 0.94

Expression of a cDNA sequence encoding human purine nucleoside phosphorylase in rodent and human cells. Mol Cell Biol (1985) 0.90

Expression of the plasmid-encoded type I dihydrofolate reductase gene in cultured mammalian cells: a novel selectable marker. Nucleic Acids Res (1988) 0.90

A repetitive sequence element 3' of the human c-Ha-ras1 gene has enhancer activity. J Cell Physiol Suppl (1987) 0.88

Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation. J Biol Chem (1989) 0.86

Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells. Nucleic Acids Res (1990) 0.83

Transplantation resistance to a Rous sarcoma virus-induced tumor in mice immunized with v-src protein. J Natl Cancer Inst (1988) 0.80

Mammalian expression of cloned cDNA sequences encoding human purine nucleoside phosphorylase and adenosine deaminase. Ann N Y Acad Sci (1985) 0.78

Expression of heterologous genes in mammalian cells. Methods Enzymol (1990) 0.78

Positive and negative modulation of H-ras transforming potential by mutations of phenylalanine-28. Mol Biol Rep (1996) 0.77

Safety issues related to the use of recombinant DNA-derived cell culture products. I. Cellular components. Dev Biol Stand (1987) 0.75

Robert A. Swanson (1947-99) Nature (2000) 0.75

Sequences 3' of the human c-Ha-ras1 gene positively regulate its expression and transformation potential. Gene Amplif Anal (1986) 0.75